journal article·2024-06Open access

VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancreatic cancer

Lu Hong, Kaiwei Xu, Ming Yang, Lubing Zhu, Chunqu Chen, Liu Xu, Weihao Zhu, Lufei Jin, Linwei Wang, Jie Lin, Jianhua Wang, Wenzhi Ren, Aiguo Wu

Abstract

Breaking the poor permeability of immune checkpoint inhibitors (ICIs) caused by the stromal barrier and reversing the immunosuppressive microenvironment are significant challenges in pancreatic cancer immunotherapy. In this study, we synthesized core-shell Fe3O4@TiO2 nanoparticles to act as carriers for loading VISTA monoclonal antibodies to form Fe3O4@TiO2@VISTAmAb (FTV). The nanoparticles are designed to target the overexpressed ICIs VISTA in pancreatic cancer, aiming to improve magnetic resonance imaging-guided sonodynamic therapy (SDT)-facilitated immunotherapy. Laser confocal microscopy and flow cytometry results demonstrate that FTV nanoparticles are specifically recognized and phagocytosed by Panc-2 cells. In vivo experiments reveal that ultrasound-triggered TiO2 SDT can induce tumor immunogenic cell death (ICD) and recruit T-cell infiltration within the tumor microenvironment by releasing damage-associated molecular patterns (DAMPs). Furthermore, ultrasound loosens the dense fibrous stroma surrounding the pancreatic tumor and increases vascular density, facilitating immune therapeutic efficiency. In summary, our study demonstrates that FTV nanoparticles hold great promise for synergistic SDT and immunotherapy in pancreatic cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Pancreatic and Hepatic Oncology Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
2. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors10.1038/s41575-021-00457-x ↗
3. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer10.1002/EXP.20210003 ↗
4. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer10.1073/pnas.1811067116 ↗
5. Immune cytolytic activity stratifies molecular subsets of human pancreatic cancer10.1158/1078-0432.CCR-16-2128 ↗
6. Phase 1 trial of CA-170, a novel oral small molecule dual inhibitor of immune checkpoints PD-1 and VISTA, in patients (pts) with advanced solid tumor or lymphomas10.1200/JCO.2017.35.15_suppl.TPS3099 ↗
7. CA-170, a first in class oral small molecule dual inhibitor of immune checkpoints PD-L1 and VISTA, demonstrates tumor growth inhibition in pre-clinical models and promotes T cell activation in Phase 1 study10.1093/annonc/mdx376.007 ↗
8. Excellent CBR and prolonged PFS in non-squamous NSCLC with oral CA-170, an inhibitor of VISTA and PD-L110.1093/annonc/mdz253.035 ↗
9. Exosomes and the future of immunotherapy in pancreatic cancer10.3390/ijms20030567 ↗
10. Pancreatic cancer stroma: an update on therapeutic targeting strategies10.1038/s41575-020-0300-1 ↗
11. Stromal biology and therapy in pancreatic cancer: a changing paradigm10.1136/gutjnl-2015-309304 ↗
12. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer10.1158/1078-0432.CCR-06-2746 ↗
13. Stratification of pancreatic ductal adenocarcinoma: combinatorial genetic, stromal, and immunologic markers10.1158/1078-0432.CCR-17-0162 ↗
14. Ultrasound-triggered nitric oxide release platform based on energy transformation for targeted inhibition of pancreatic tumor10.1021/acsnano.6b04921 ↗
15. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors10.1016/j.ijpharm.2013.07.067 ↗
16. IGF1 receptor-targeted black TiO(2) nanoprobes for MRI-guided synergetic photothermal-chemotherapy in drug resistant pancreatic tumor10.1186/s12951-022-01525-3 ↗
17. A near infrared light triggered hydrogenated black TiO2 for cancer photothermal therapy10.1002/adhm.201500273 ↗
18. Recent progress of potentiating immune checkpoint blockade with external stimuli-an industry perspective
19. Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects10.5411/wji.v4.i1.1 ↗
20. Photooxidation and Phototoxicity of pi-extended squaraines10.1021/jm901727j ↗
21. Absorption, fluorescence, and two-photon excitation ability of 5-Phenylisolidolo[2,1-a]quinolines10.1021/acsomega.9b04070 ↗
22. In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy10.1021/jm901823u ↗
23. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer10.1016/j.jconrel.2018.04.018 ↗
24. Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal10.1016/j.ejpb.2019.04.003 ↗
25. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer10.1016/j.canlet.2021.06.003 ↗
26. Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer10.1016/j.jconrel.2021.07.020 ↗
27. Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo/immuno glioblastoma therapy
28. Collagenase-Loaded H-TiO(2) nanoparticles enhance ultrasound imaging-guided sonodynamic therapy in a pancreatic carcinoma xenograft model via digesting stromal barriers10.1021/acsami.2c08951 ↗
29. Titanium dioxide nanoparticle-entrapped polyion complex micelles generate singlet oxygen in the cells by ultrasound irradiation for sonodynamic therapy10.1039/C2BM00066K ↗
30. Ginsenoside Rk1-loaded manganese-doped hollow titania for enhancing tumor sonodynamic therapy via upregulation of intracellular reactive oxygen species10.1021/acsami.3c03476 ↗
31. Hydrothermal etching assisted crystallization: a facile route to functional yolk-shell titanate microspheres with ultrathin nanosheets-assembled double shells10.1021/ja2055287 ↗
32. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy10.1038/s41467-019-12771-9 ↗
33. Photothermal-activatable Fe(3)O(4) superparticle nanodrug carriers with PD-L1 immune checkpoint blockade for anti-metastatic cancer immunotherapy10.1021/acsami.8b05876 ↗
34. Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer10.1186/s12951-022-01459-w ↗
35. Catalytically active CoFe(2)O(4) nanoflowers for augmented sonodynamic and chemodynamic combination therapy with elicitation of robust immune response10.1021/acsnano.1c03128 ↗
36. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy10.1016/j.biomaterials.2020.120636 ↗
37. A multifunctional nanovaccine based on L-arginine-loaded black mesoporous titania: ultrasound-triggered synergistic cancer sonodynamic therapy/gas therapy/immunotherapy with remarkably enhanced efficacy10.1002/smll.202005728 ↗
38. Identification of treated Baltic amber by FTIR and FT-Raman - a feasibility study10.1016/j.saa.2022.121404 ↗
39. A novel Pt-TiO2 heterostructure with oxygen-deficient layer as bilaterally enhanced sonosensitizer for synergistic chemo-sonodynamic cancer therapy10.1002/adfm.201908598 ↗
40. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
41. Immunogenic cell death in cancer therapy10.32607/actanaturae.11523 ↗
42. Targeting immunogenic cell death in cancer10.1002/1878-0261.12851 ↗
43. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer10.1038/nm.4308 ↗
44. Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients10.1038/modpathol.2017.89 ↗
45. Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA10.1186/s12865-021-00446-4 ↗